NOD2 and Crohn disease: NOD2 protects ISCs against reactive oxygen species toxicity (Levy et al., 2020), and mutations in NOD2 are associated with Crohn’s disease and intestinal tumorigenesis (Couturier-Maillard et al., 2013).